https://eprnews.com/ Bioz Has Partnered With NEB to Empower Life Science Researchers Press Release (ePRNews.com) - LOS ALTOS, Calif. - Jun 13, 2019 - Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with the world leader in the discovery and production of enzymes for molecular biology applications: New England Biolabs® (NEB®). NEB was founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life science industry. NEB is renowned for consistently providing exceptionally high-quality products coupled with unsurpassed researcher support. NEB’s products are regularly cited in top tier peer-reviewed journals, with over 300,000 citations to date. With this partnership, NEB is leveraging the deep AI technology that Bioz has developed over several years, which incorporates the latest advances in Natural Language Processing (NLP) and Machine Learning (ML). This technology now enables NEB’s customers in academia, biopharma, and other life science research laboratories to access real-world NEB product applications that come directly from scientific articles. The applications are displayed on the NEB website within Bioz Badges, iFrame widgets (i.e. a Product Citation Tool) that include product-specific article citations. Bioz Badges enrich each product listing with in-depth details and usage context, extracted from peer-reviewed scientific publications, adding another level of confidence to the buying process of each and every product. Bioz Badges incorporate data transparency, data validation and increase researcher confidence to improve the overall product selection experience of researchers who visit the NEB website. “I am very proud to partner with NEB, to provide their researchers with peer-reviewed product-specific data,” said Dr. Karin Lachmi, co-founder and CSO of Bioz. “NEB’s longstanding stellar reputation in the industry means that more researchers are now able to obtain value from a powerful unparalleled resource for evidence-based guidance that is based on the source that researchers trust most, scientific articles.” Dr. Lachmi added that “This partnership surfaces the latest NEB product citations, enhancing transparency and objectivity, and thus supporting and advancing research around the world, both in academia and in biopharma.”